Ra medical systems, inc. (RMED)
Income statement / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Sep'17
Net revenue
Total net revenue

1,374

1,390

1,908

2,153

1,748

1,988

2,064

1,236

969

1,291

Cost of revenue
Total cost of revenue

1,584

1,750

2,425

2,733

1,942

1,200

1,280

990

736

693

Gross loss

-210

-360

-517

-580

-194

788

784

246

233

598

Operating expenses
Selling, general and administrative

6,285

8,642

15,889

13,789

13,229

14,815

5,366

7,615

2,639

1,904

Research and development

1,295

838

1,182

979

1,531

1,244

224

1,022

286

413

Total operating expenses

7,580

9,480

17,071

14,768

14,760

16,059

5,590

8,637

2,925

2,317

Operating loss

-7,790

-9,840

-17,588

-15,348

-14,954

-15,271

-4,806

-8,391

-2,692

-1,719

Other income (expense), net
Interest income

114

168

245

297

328

-

-

-

-

-

Interest expense

25

64

72

66

48

11

1

1

1

1

Total other income (expense), net

89

104

173

231

280

341

-1

-1

-1

-

Total other expense

-

-

-

-

-

-

-

-

-

1

Loss before income tax expense

-7,701

-9,736

-17,415

-15,117

-14,674

-14,930

-4,807

-8,392

-2,693

-1,720

Income tax expense

-

-

3

5

-

-

-

3

-

-

Net loss

-7,701

-9,743

-17,418

-15,122

-14,674

-14,937

-4,807

-8,395

-2,693

-1,720

Basic and diluted net loss per share

-0.56

-0.71

-1.30

-1.16

-1.16

-1.38

-0.59

-1.03

-0.34

-0.23

Basic and diluted weighted average common shares outstanding

13,770

13,521

13,370

13,000

12,693

12,665

8,204

8,113

7,938

7,479

Product Sales [Member]
Total net revenue

586

603

1,078

1,284

894

1,201

1,248

475

235

-

Total cost of revenue

964

1,008

1,518

1,935

1,395

777

886

647

342

-

Service and Other [Member]
Total net revenue

788

787

830

869

854

787

816

761

734

-

Total cost of revenue

620

742

907

798

547

423

394

343

394

-